Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Fast Forward

JPET Fast Forward contains papers in manuscript form that have been accepted and published in JPET but have not been copyedited and have not been assigned to an issue of the journal. Copyediting may lead to some differences between the Fast Forward version and the final version. There may also be differences in the quality of the graphics. The publication date appears below each title followed by the article's unique Digital Object Identifier (DOI).

April 12, 2021

  • You have access
    Rosuvastatin inhibits the apoptosis of platelet-derived growth factor-stimulated vascular smooth muscle cells by inhibiting p38 via autophagy
    Jun-Hwan Jo, Hyun-Soo Park, Do-Hyung Lee, Joo-Hui Han, Kyung-Sun Heo and Chang-Seon Myung
    Journal of Pharmacology and Experimental Therapeutics April 12, 2021, JPET-AR-2021-000539; DOI: https://doi.org/10.1124/jpet.121.000539

April 09, 2021

  • You have access
    Increasing effects of selective 5-HT2C receptor stimulation on evoked momentary urethral closure in female rats and humans
    Izumi Kamo, Hiroshi Nagata, Gale O'Connell, Takuya Kato, Akio Imanishi, Masako Kuno, Satoshi Okanishi, Kyoko Yoshikawa and Yuya Nishiyama
    Journal of Pharmacology and Experimental Therapeutics April 9, 2021, JPET-AR-2021-000573; DOI: https://doi.org/10.1124/jpet.121.000573

April 05, 2021

  • You have access
    Poly (ADP-ribose) polymerase inhibitors for arsenic trioxide-resistant acute promyelocytic leukemia: synergistic in vitro antitumor effects with hypomethylating agents or high-dose vitamin C
    Manuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella Faraoni
    Journal of Pharmacology and Experimental Therapeutics April 5, 2021, JPET-AR-2021-000537; DOI: https://doi.org/10.1124/jpet.121.000537
  • You have access
    Ginsenoside Ro ameliorates high fat diet-induced obesity and insulin resistance in mice via activation of the TGR5 pathway
    Lin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li Yang
    Journal of Pharmacology and Experimental Therapeutics April 5, 2021, JPET-AR-2020-000435; DOI: https://doi.org/10.1124/jpet.120.000435

April 01, 2021

  • You have access
    Development of CVN424: a selective and novel GPR6 inverse agonist effective in models of Parkinson's Disease
    Nicola L Brice, Hans H Schiffer, Holger Monenschein, Victoria J Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J Russell Burley, Huikai Sun, Louise Dickson, Sean T Murphy, Nidhi Kaushal, Steven Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A Dawson, Stephen H Hitchcock and Mark B Carlton
    Journal of Pharmacology and Experimental Therapeutics April 1, 2021, JPET-AR-2020-000438; DOI: https://doi.org/10.1124/jpet.120.000438

March 30, 2021

  • You have access
    Brain Concentrations of Methylone and its Metabolites After Systemic Methylone Administration: Relationship to Pharmacodynamic Effects
    Nicole Centazzo, Michel R Chojnacki, Joshua S Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C Rice, Michael H Baumann and Marta Concheiro
    Journal of Pharmacology and Experimental Therapeutics March 30, 2021, JPET-AR-2021-000531; DOI: https://doi.org/10.1124/jpet.121.000531

March 29, 2021

  • You have access
    Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters
    Michele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin Lochner
    Journal of Pharmacology and Experimental Therapeutics March 29, 2021, JPET-AR-2020-000449; DOI: https://doi.org/10.1124/jpet.120.000449

March 26, 2021

  • You have access
    Circ-KRT6C promotes malignant progression and immune evasion of colorectal cancer through miR-485-3p/PDL1 axis
    Zhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang Chen
    Journal of Pharmacology and Experimental Therapeutics March 26, 2021, JPET-AR-2021-000518; DOI: https://doi.org/10.1124/jpet.121.000518

March 23, 2021

  • You have access
    Inhibition of G6PD activity attenuates right ventricle pressure and hypertrophy elicited by VEGFR inhibitor + hypoxia
    Atsushi Kitagawa, Christina Jacob, Allan Jordan, Ian Waddell, Ivan F Mcmurtry and Sachin A Gupte
    Journal of Pharmacology and Experimental Therapeutics March 23, 2021, JPET-AR-2020-000166; DOI: https://doi.org/10.1124/jpet.120.000166

March 22, 2021

  • You have access
    Synergistic pharmacodynamic effects of gemcitabine and fibroblast growth factor receptor inhibitors on pancreatic cancer cell cycle kinetics and proliferation
    Qingxiang Lin, Zhicheng Qian, William J Jusko, Donald E. Mager, Wen Wee Ma and Robert M. Straubinger
    Journal of Pharmacology and Experimental Therapeutics March 22, 2021, JPET-AR-2020-000412; DOI: https://doi.org/10.1124/jpet.120.000412

March 16, 2021

  • You have access
    AM833 is a novel agonist of calcitonin family G protein-coupled receptors: pharmacological comparison to six selective and non-selective agonists
    Madeleine M Fletcher, Peter Keov, Tin T Truong, Grace Mennen, Caroline A Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R Clausen, Denise Wootten and Patrick M. Sexton
    Journal of Pharmacology and Experimental Therapeutics March 16, 2021, JPET-AR-2021-000567; DOI: https://doi.org/10.1124/jpet.121.000567

March 15, 2021

  • You have access
    Chronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
    Yixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping Cheng
    Journal of Pharmacology and Experimental Therapeutics March 15, 2021, JPET-AR-2020-000361; DOI: https://doi.org/10.1124/jpet.120.000361
  • You have access
    Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition
    Chad Richard Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. Woods
    Journal of Pharmacology and Experimental Therapeutics March 15, 2021, JPET-AR-2020-000337; DOI: https://doi.org/10.1124/jpet.120.000337

March 12, 2021

  • You have access
    A novel integrated pharmacokinetic-pharmacodynamic model to evaluate combination therapy and determine in vivo synergism
    Young Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming Yu
    Journal of Pharmacology and Experimental Therapeutics March 12, 2021, JPET-AR-2021-000584; DOI: https://doi.org/10.1124/jpet.121.000584

March 11, 2021

  • You have access
    Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II-induced atherosclerosis, abdominal aortic aneurysms, and hypertension
    Yasir Alsiraj, Sean Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa Cassis
    Journal of Pharmacology and Experimental Therapeutics March 11, 2021, JPET-AR-2021-000525; DOI: https://doi.org/10.1124/jpet.121.000525

February 18, 2021

  • You have access
    SAR340835, a novel selective NCX inhibitor, improves cardiac function and restores sympathovagal balance in Heart Failure.
    Michel Pelat, Fabrice Barbe, Cyril Daveu, Laetitia Ly-Nguyen, Thomas Lartigue, Suzanne Marque, Georges Tavares, Veronique Ballet, Jean-Michel Guillon, Klaus Steinmeyer, Klaus Wirth, Heinz Gögelein, Petra Arndt, Nils Rackelmann, John Weston, Patrice Bellevergue, Gary McCort, Marc Trellu, Laurence Lucats, Philippe Beauverger, Marie-Pierre Pruniaux-Harnist, Philip Janiak and Frédérique Chézalviel-Guilbert
    Journal of Pharmacology and Experimental Therapeutics February 18, 2021, JPET-AR-2020-000238; DOI: https://doi.org/10.1124/jpet.120.000238

View by section

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics